PMID: 9529328May 16, 1998Paper

Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity

The Journal of Experimental Medicine
M M GiulianiM Pizza

Abstract

Heat-labile Escherichia coli enterotoxin (LT) has the innate property of being a strong mucosal immunogen and adjuvant. In the attempt to reduce toxicity and maintain the useful immunological properties, several LT mutants have been produced. Some of these are promising mucosal adjuvants. However, so far, only those that were still toxic maintained full adjuvanticity. In this paper we describe a novel LT mutant with greatly reduced toxicity that maintains most of the adjuvanticity. The new mutant (LTR72), that contains a substitution Ala --> Arg in position 72 of the A subunit, showed only 0.6% of the LT enzymatic activity, was 100,000-fold less toxic than wild-type LT in Y1 cells in vitro, and was at least 20 times less effective than wild-type LT in the rabbit ileal loop assay in vivo. At a dose of 1 microg, LTR72 exhibited a mucosal adjuvanticity, similar to that observed with wild-type LT, better than that induced by the nontoxic, enzymatically inactive LTK63 mutant, and much greater than that of the recombinant B subunit. This trend was consistent for both the amounts and kinetics of the antibody induced, and priming of antigen-specific T lymphocytes. The data suggest that the innate high adjuvanticity of LT derives from t...Continue Reading

References

Jan 1, 1992·Vaccine·J HolmgrenH Wigzell
Jan 1, 1991·Methods in Enzymology·D M Gill, M J Woolkalis
Sep 21, 1989·The New England Journal of Medicine·M FieldE B Chang
Jan 1, 1984·Methods in Enzymology·J Moss, M Vaughan
Jul 1, 1980·Infection and Immunity·J D ClementsR A Finkelstein
Oct 15, 1981·Biochemical and Biophysical Research Communications·C Y LaiL K Duffy
Jan 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·E K SpicerD E Schafer
Oct 1, 1994·Molecular Microbiology·M DomenighiniR Rappuoli
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·G DouceG Dougan
Mar 1, 1996·The Journal of Infectious Diseases·I TakahashiJ R McGhee
Mar 1, 1996·Infection·H M HasselhornF W Tiller
Apr 15, 1997·The Journal of Immunology : Official Journal of the American Association of Immunologists·L C AgrenN Y Lycke
May 13, 1997·Proceedings of the National Academy of Sciences of the United States of America·S YamamotoJ R McGhee

❮ Previous
Next ❯

Citations

Jun 5, 2003·International Journal for Parasitology·Manmohan Singh, Derek T O'Hagan
Oct 28, 1998·Molecular Aspects of Medicine·G Del GiudiceR Rappuoli
Jul 14, 2001·Trends in Biotechnology·E J RyanK H Mills
Feb 22, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·M SinghD T O'Hagan
Dec 14, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Samuel PineDerek O'Hagan
Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·G J Russell-Jones
Sep 1, 2000·Advanced Drug Delivery Reviews·S A HammondG M Glenn
Aug 23, 2001·Advanced Drug Delivery Reviews·M Vajdy, D T O'Hagan
Oct 3, 1999·Vaccine·G Del Giudice, R Rappuoli
Oct 31, 2002·Research in Microbiology·Simon ClareGordon Dougan
Mar 23, 2000·FEMS Immunology and Medical Microbiology·E Medina, C A Guzmán
Dec 28, 1999·Microbes and Infection·M J McCluskie, H L Davis
Sep 22, 2001·Biomolecular Engineering·D T O'HaganM Singh
Aug 1, 2000·Pharmaceutical Science & Technology Today·C D Partidos
Mar 17, 2001·Scandinavian Journal of Immunology·M YamamotoH Kiyono
Mar 17, 2001·Scandinavian Journal of Immunology·C P SimmonsG Dougan
Apr 6, 2006·Avian Pathology : Journal of the W.V.P.A·Yelena Vasserman, Jacob Pitcovski
Oct 25, 2000·Journal of Pediatric Gastroenterology and Nutrition·M M Levine
Jun 30, 2000·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·G DouganC Simmons
Nov 20, 2004·Immunology and Cell Biology·Michael VajdyManmohan Singh
Apr 22, 2011·Clinical and Vaccine Immunology : CVI·Kenneth C BagleyTimothy R Fouts
Sep 16, 2011·Clinical and Vaccine Immunology : CVI·Roger W BarretteLawrence K Silbart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.